EN
ページタイトル画像

Respirology

Overview

In Respiratory Medicine, we have been and will be conducting medical services, medical research and educational activities, learning towards respiratory diseases, regarding respiratory structure and functions, pulmonary pathophysiology, pathobiology and molecular biology. Respiratory diseases include 1) pulmonary circulatory disorders such as pulmonary hypertension and pulmonary thromboembolism, 2) interstitial pneumonia such as pulmonary fibrosis, 3) chronic obstructive pulmonary disease, 4) sleep apnea syndrome, 5) pulmonary infectious diseases, 6) allergic diseases such as bronchial asthma, 7) lung malignancies, and so on.

Professor:
Takuji Suzuki, MD

TEL:+81-43-222-7171
FAX:+81-43-226-2176
e-mail:suzutaku●chiba-u.jp
URL: http://www.m.chiba-u.ac.jp/class/respir/index.html

※　Please change "●" mark to at-mark if you send emails.

11.jpg

Research & Education

11図.jpg

The aims of research to be elucidated are as follows.

  1. Remodeling of pulmonary artery in pulmonary arterial hypertension (PAH) and therapy for PAH.
  2. Development and progression of chronic pulmonary thromboembolic hypertension (CTEPH) and therapy for CTEPH.
  3. Cell death, remodeling and repair process in pulmonary diseases.
  4. Adaptation to hypoxia.
  5. Pathogenesis and therapy for interstitial lung diseases.
  6. Integrated omics analysis in respiratory diseases to search for new biomarkers and therapeutic targets.
  7. Pathogenesis and therapy for chronic obstructive pulmonary disease (COPD).
  8. Pathophysiology and therapy for sleep apnea syndrome.
  9. Pathophysiology and therapy for pulmonary infectious diseases.
  10. Diagnosis and therapeutic strategies for pulmonary malignant diseases.

Recent Publications

Takahashi Y, et al. Functional Roles for CD26/DPP4 in Mediating Inflammatory Responses of Pulmonary Vascular Endothelial Cells. Cells. 10(12):3508. 2021

Shionoya Y, et al. Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study. PLoS One. 16(9):e0256977. 2021.

Yamamoto K, et al. Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension. Int J Cardiol. 15;299:263-270.2020